IRCT20170611034458N2
Completed
Phase 3
Exploring the effect of Crocin supplementation on glycemic indexes, oxidative stress factors and inflammation biomarkers in patients with type 2 diabetes treated by metformin
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with type 2 diabetes treated by metformin
- •Aged 35\-75 years old
Exclusion Criteria
- •Hypertension
- •Patients with other endocrine, liver, kidney, inflammatory and lung disorders
- •Taking metformin in combination with other anti\-diabetic drugs
- •Take any other antioxidant supplement
- •Alcohol\-drug abuse
- •Pregnant women
- •Patients with type 1 diabetes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Evaluation of the effect of crocin in the treatment of cystoid macular edema secondary to retinitis pigmentosaIRCT20201219049753N2Mashhad University of Medical Sciences20
Recruiting
Phase 2
Efficacy and Safety of Crocin Supplementation in Patients With Central SerousChorioretinopathy (CSCR)Central serous chorioretinopathy.Central serous chorioretinopathyH35.71IRCT20110811007297N7Shiraz University of Medical Sciences40
Recruiting
Phase 2
Evaluation of the effect of krocina in patients with Diminished ovarian reserveDiminished ovarian reserve.IRCT20220516054872N1Shahid Beheshti University of Medical Sciences30
Recruiting
Phase 3
Therapeutic effect of crocin along with chemotherapy regimens in breast cancerBreast cancer.Malignant neoplasm of breast of unspecified siteC50.9IRCT20131017015044N3Mashhad University of Medical Sciences100
Not yet recruiting
Phase 3
Effect of crocin on depression induced by amphetamine withdrawalIRCT20160804029191N3Mashhad University of Medical Sciences60